FACTORS ASSOCIATED WITH INCONSISTENT DORNASE ALFA THERAPY IN PATIENTS WITH CYSTIC FIBROSIS

被引：0
|
作者：
Sawicki, G. S. [1 ]
VanDevanter, D. [2 ]
Schechter, M. S. [3 ]
Millar, S. [4 ]
Xu, Y. [5 ]
Pasta, D. [4 ]
Morgan, W. [6 ]
Konstan, M. [2 ]
机构：
[1] Childrens Hosp, Boston, MA 02115 USA
[2] Case Western Reserve Univ, Sch Med, Cleveland, OH USA
[3] Emory Univ, Sch Med, Atlanta, GA USA
[4] ICON Late Phase & Outcomes Res, San Francisco, CA USA
[5] Genentech Inc, San Francisco, CA 94080 USA
[6] Univ Arizona, Tucson, AZ USA
来源：
PEDIATRIC PULMONOLOGY | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：356 / 356
页数：1
相关论文
共 50 条
  • [21] The role of dornase alfa in the treatment of cystic fibrosis
    Cramer, GW
    Bosso, JA
    ANNALS OF PHARMACOTHERAPY, 1996, 30 (06) : 656 - 661
  • [22] Dornase alfa -: Pulmozyme® -: Treatment of cystic fibrosis
    不详
    DRUGS OF THE FUTURE, 2001, 26 (06) : 588 - 588
  • [23] DORNASE ALFA LICENSED FOR CYSTIC-FIBROSIS TREATMENT
    NIGHTINGALE, SL
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (07): : 494 - 494
  • [24] Cystic fibrosis clinical characteristics associated with dornase alfa treatment regimen change
    VanDevanter, Donald R.
    Craib, Marcia L.
    Pasta, David J.
    Millar, Stefanie J.
    Morgan, Wayne J.
    Konstan, Michael W.
    PEDIATRIC PULMONOLOGY, 2018, 53 (01) : 43 - 49
  • [25] Dornase alfa and progression of lung disease in cystic fibrosis
    Konstan, Michael W.
    PEDIATRIC PULMONOLOGY, 2008, 43 (09) : S24 - S28
  • [26] Dornase alfa: A new option in the management of cystic fibrosis
    Witt, DM
    Anderson, L
    PHARMACOTHERAPY, 1996, 16 (01): : 40 - 48
  • [27] Dornase alfa in early cystic fibrosis lung disease
    Robinson, PJ
    PEDIATRIC PULMONOLOGY, 2002, 34 (03) : 237 - 241
  • [28] Comparison of inhaled mannitol/dornase alfa combination and daily dornase alfa alone in children with cystic fibrosis
    Tural, Dilber Ademhan
    Yalcin, Ebru
    Emiralioglu, Nagehan
    Ozsezen, Beste
    Sunman, Birce
    Buyuksahin, Halime Nayir
    Guzelkas, Ismail
    Dogru, Deniz
    Ozcelik, Ugur
    Kiper, Nural
    PEDIATRIC PULMONOLOGY, 2022, 57 (01) : 142 - 151
  • [29] Treatment of chronic rhinosinusitis with dornase alfa in patients with cystic fibrosis: a systematic review
    Shah, Gopi B.
    De Keyzer, Linde
    Russell, Joy A.
    Halderman, Ashleigh
    INTERNATIONAL FORUM OF ALLERGY & RHINOLOGY, 2018, 8 (06) : 729 - 736
  • [30] ANALYSIS OF EFFICACY AND SAFETY OF DORNASE ALFA IN THE TREATMENT OF CYSTIC FIBROSIS
    Kaczor, M.
    Wojcik, R.
    Rolka, M.
    Banas, P.
    Niewiara, L.
    Kaczynski, L.
    Russel-Szymczyk, M.
    Szkultecka-Debek, M.
    VALUE IN HEALTH, 2011, 14 (07) : A488 - A488
12345